Clinical Trial

Etude PROTECT : Prognostic Role of Tapse Evaluation in Children's bronchioliTis

Study acronym: PROTECT
Completed
View on ClinicalTrials.gov →
Summary
In this prospective study, we aim to evaluate the association between an echocardiographic marker of right ventricular systolic function, the TAPSE (Tricuspid Annular Plane Systolic Excursion), and poor outcome in patients admitted to Pediatric Intensive Care Unit (PICU) for Acute Bronchiolitis (AB).
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-09-29.
Trial Details
NCT Number NCT07209956
Lead Sponsor University Hospital, Bordeaux
Conditions Bronchiolitis, Viral
Enrollment 46 participants
Start Date 2022-10-18
Primary Completion 2022-10-18 (estimated)
Study Completion 2023-01-09 (estimated)
Updated on ClinicalTrials.gov 2026-05-22